Literature DB >> 15851031

Structural basis of pore formation by the bacterial toxin pneumolysin.

Sarah J Tilley1, Elena V Orlova, Robert J C Gilbert, Peter W Andrew, Helen R Saibil.   

Abstract

The bacterial toxin pneumolysin is released as a soluble monomer that kills target cells by assembling into large oligomeric rings and forming pores in cholesterol-containing membranes. Using cryo-EM and image processing, we have determined the structures of membrane-surface bound (prepore) and inserted-pore oligomer forms, providing a direct observation of the conformational transition into the pore form of a cholesterol-dependent cytolysin. In the pore structure, the domains of the monomer separate and double over into an arch, forming a wall sealing the bilayer around the pore. This transformation is accomplished by substantial refolding of two of the four protein domains along with deformation of the membrane. Extension of protein density into the bilayer supports earlier predictions that the protein inserts beta hairpins into the membrane. With an oligomer size of up to 44 subunits in the pore, this assembly creates a transmembrane channel 260 A in diameter lined by 176 beta strands.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15851031     DOI: 10.1016/j.cell.2005.02.033

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  169 in total

1.  Continuous differential impedance spectroscopy of single cells.

Authors:  Daniele Malleo; J Tanner Nevill; Luke P Lee; Hywel Morgan
Journal:  Microfluid Nanofluidics       Date:  2009-12-10       Impact factor: 2.529

2.  Perforin activity at membranes leads to invaginations and vesicle formation.

Authors:  Tilen Praper; Andreas F-P Sonnen; Ales Kladnik; Alberto O Andrighetti; Gabriella Viero; Keith J Morris; Emanuela Volpi; Lorenzo Lunelli; Mauro Dalla Serra; Christopher J Froelich; Robert J C Gilbert; Gregor Anderluh
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-15       Impact factor: 11.205

3.  Structure of complement C6 suggests a mechanism for initiation and unidirectional, sequential assembly of membrane attack complex (MAC).

Authors:  Alexander E Aleshin; Ingrid U Schraufstatter; Boguslaw Stec; Laurie A Bankston; Robert C Liddington; Richard G DiScipio
Journal:  J Biol Chem       Date:  2012-01-20       Impact factor: 5.157

4.  Monomer-monomer interactions propagate structural transitions necessary for pore formation by the cholesterol-dependent cytolysins.

Authors:  Eileen M Hotze; Elizabeth Wilson-Kubalek; Allison J Farrand; Lori Bentsen; Michael W Parker; Arthur E Johnson; Rodney K Tweten
Journal:  J Biol Chem       Date:  2012-05-29       Impact factor: 5.157

Review 5.  Membrane assembly of the cholesterol-dependent cytolysin pore complex.

Authors:  Eileen M Hotze; Rodney K Tweten
Journal:  Biochim Biophys Acta       Date:  2011-07-31

6.  Single-particle electron microscopy in the study of membrane protein structure.

Authors:  Rita De Zorzi; Wei Mi; Maofu Liao; Thomas Walz
Journal:  Microscopy (Oxf)       Date:  2015-10-15       Impact factor: 1.571

Review 7.  Pore-forming toxins: ancient, but never really out of fashion.

Authors:  Matteo Dal Peraro; F Gisou van der Goot
Journal:  Nat Rev Microbiol       Date:  2015-12-07       Impact factor: 60.633

Review 8.  Listeriolysin O: from bazooka to Swiss army knife.

Authors:  Suzanne E Osborne; John H Brumell
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-08-05       Impact factor: 6.237

9.  Intermedilysin-receptor interactions during assembly of the pore complex: assembly intermediates increase host cell susceptibility to complement-mediated lysis.

Authors:  Stephanie LaChapelle; Rodney K Tweten; Eileen M Hotze
Journal:  J Biol Chem       Date:  2009-03-16       Impact factor: 5.157

10.  Cholesterol exposure at the membrane surface is necessary and sufficient to trigger perfringolysin O binding.

Authors:  John J Flanagan; Rodney K Tweten; Arthur E Johnson; Alejandro P Heuck
Journal:  Biochemistry       Date:  2009-05-12       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.